全文获取类型
收费全文 | 12400篇 |
免费 | 736篇 |
国内免费 | 132篇 |
专业分类
耳鼻咽喉 | 302篇 |
儿科学 | 157篇 |
妇产科学 | 174篇 |
基础医学 | 2130篇 |
口腔科学 | 173篇 |
临床医学 | 819篇 |
内科学 | 2373篇 |
皮肤病学 | 503篇 |
神经病学 | 1001篇 |
特种医学 | 1134篇 |
外科学 | 1685篇 |
综合类 | 37篇 |
一般理论 | 4篇 |
预防医学 | 331篇 |
眼科学 | 387篇 |
药学 | 869篇 |
中国医学 | 95篇 |
肿瘤学 | 1094篇 |
出版年
2023年 | 72篇 |
2022年 | 242篇 |
2021年 | 413篇 |
2020年 | 230篇 |
2019年 | 319篇 |
2018年 | 351篇 |
2017年 | 304篇 |
2016年 | 459篇 |
2015年 | 624篇 |
2014年 | 696篇 |
2013年 | 809篇 |
2012年 | 1185篇 |
2011年 | 1159篇 |
2010年 | 680篇 |
2009年 | 566篇 |
2008年 | 724篇 |
2007年 | 747篇 |
2006年 | 621篇 |
2005年 | 576篇 |
2004年 | 481篇 |
2003年 | 447篇 |
2002年 | 364篇 |
2001年 | 225篇 |
2000年 | 210篇 |
1999年 | 144篇 |
1998年 | 75篇 |
1997年 | 60篇 |
1996年 | 38篇 |
1995年 | 26篇 |
1994年 | 25篇 |
1993年 | 22篇 |
1992年 | 54篇 |
1991年 | 46篇 |
1990年 | 44篇 |
1989年 | 27篇 |
1988年 | 30篇 |
1987年 | 30篇 |
1986年 | 19篇 |
1985年 | 8篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1981年 | 6篇 |
1980年 | 5篇 |
1979年 | 13篇 |
1978年 | 8篇 |
1974年 | 9篇 |
1971年 | 4篇 |
1970年 | 7篇 |
1969年 | 4篇 |
1967年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
Park Jae Joon Kim Kyeongmin Choi Jin Yong Shim Sung Ryul Kim Jae Heon 《International urology and nephrology》2021,53(8):1563-1581
International Urology and Nephrology - To date, several studies have reported inconsistent findings regarding the mortality risk faced by living kidney donors and controls. Our study assessed the... 相似文献
42.
Kim Si Hyun Park Jae Joon Kim Ki Hong Yang Hee Jo Kim Doo Sang Lee Chang Ho Jeon Youn Soo Shim Sung Ryul Kim Jae Heon 《International urology and nephrology》2021,53(9):1733-1746
International Urology and Nephrology - Late onset hypogonadism (LOH) is an age-dependent reduction of testosterone associated with alterations of metabolic profile, including glucose control,... 相似文献
43.
Jun Ho Kim Eunsun Oh Young Cheol Yoon Do Kyung Lee Sung-Sahn Lee Joon Ho Wang 《Arthroscopy》2021,37(1):209-221
44.
Sara Kim Berik Rovgaliyev Jeong-Moo Lee Kwang-Woong Lee Suk Kyun Hong Jae-Hyung Cho Kyung Chul Yoon Nam-Joon Yi Kyung-Suk Suh 《Transplantation proceedings》2021,53(1):200-206
BackgroundSeveral studies have reported that solid organ transplant recipients have a high risk for malignant tumors because the suppressed immune system fails in preventing malignant transformations. De novo malignancy after transplantation is the most common cause of death in the late period after liver transplant (LT). This study investigated the clinical significance of de novo malignancy after LT, and it is the largest study based in Korea to report long-term follow-up results associated with de novo malignancy after LT.MethodsData of 1793 adults who underwent LT in Seoul National University Hospital were retrospectively collected, and medical charts and data from the Ministry of Public Administration and Security were reviewed to examine the causes of death and de novo malignancy status. The Fisher exact test and Kaplan-Meier survival analysis were used to analyze the data.ResultsOf the 1793 recipients, 27 died of de novo malignancies. Of 875 hepatocellular carcinoma (HCC) patients, 12 died, and of 918 non-HCC patients, 15 died. De novo malignancy was the main cause of death at 5 years after LT but was not in the initial 5 years. In Korea the most common cancers that developed after LT were gastric cancer (21.4%) and lymphoma (14.3%). De novo HCC in non-HCC cases was found in 2 patients.ConclusionDe novo malignancy is a key factor affecting long-term survival after LT. Therefore, regular screening and education are important for improving long-term survival and quality of life in these patients after LT. 相似文献
45.
Xuan-Mei Piao Ho Won Kang Pildu Jeong Young Joon Byun Hee Youn Lee Kyeong Kim Sung Phil Seo Won Tae Kim Jong-Young Lee Yun-Sok Ha Yung Hyun Choi Sung-Kwon Moon Seok Joong Yun Wun-Jae Kim 《Urologic oncology》2021,39(4):237.e21-237.e29
BackgroundThere is an increasing demand for prognostic immune biomarkers of cancer. The prognostic significance of immune markers has been shown for various cancers, but biomarkers of bladder cancer (BCa) have not been fully evaluated. To clarify the role of human leukocyte antigen DR alpha chain (HLA-DRA) in BCa development, we examined expression of HLA-DRA mRNA in tissue samples of non-muscle invasive bladder cancer (NMIBC) and muscle invasive bladder cancer (MIBC).Materials and MethodsTissues of 96 NMIBC, 43 MIBC and 59 controls comprising noncancerous BCa surrounding tissues were used to examine the expression of HLA-DRA gene by real-time polymerase chain reaction. The expression of up-stream genes regulating HLA-DRA were also measured to explain the role of HLA-DRA in BCa.ResultsPatients with high grade NMIBC showed higher expression of HLA-DRA than those with low grade NMIBC (P < 0.05). In addition, NMIBC patients who progressed to MIBC showed high expression of HLA-DRA mRNA. Kaplan-Meier analysis showed that NMIBC patients with low expression of HLA-DRA had better progression-free survival than those with high expression (P = 0.004). Moreover, the expression of genes regulating HLA-DRA varied in NMIBC and MIBC, indicating a different immunoregulation effect of HLA-DRA in both cancers.ConclusionsHigh expression of HLA-DRA in NMIBC patients has implications for patient stratification strategies, as well as for BCa tumor immunology. 相似文献
46.
Jung Kwon Kim Hoyoung Ryu Myong Kim Eun-Kyung Kwon Hakmin Lee Sang Joon Park Seok-Soo Byun 《BJU international》2021,127(5):567-574
47.
Sarah Suh Emily Hetzel Katie Alter-Troilo Kathleen Lak Jon C. Gould Tammy L. Kindel Rana M. Higgins 《Surgery for obesity and related diseases》2021,17(8):1480-1488
BackgroundPreoperative carbohydrate loading is a component of Enhanced Recovery After Surgery (ERAS) protocols, but there is limited literature in bariatric surgery patients.ObjectivesThe objective of this study was to characterize the impact of preoperative carbohydrate loading on postoperative bariatric surgery outcomes.SettingUniversity Hospital.MethodsPatients undergoing a primary minimally invasive Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2018 and 2020 were randomized to standard management or intervention. Standard management patients were nothing by mouth (NPO) after midnight prior to surgery. Intervention patients consumed 2 carbohydrate drinks: 1 the night before and another 3 hours prior to surgery. Primary outcomes analyzed included postoperative nausea and vomiting (PONV), length of stay, and overall complications.ResultsIn total, 134 patients were analyzed: 64 intervention (47.8%) and 70 (52.2%) standard. In the end, 7% and 15% of patients were lost to follow-up at 6-weeks and 3-months, respectively. There was no statistically significant difference in length of stay (2.0 ± 1.2 vs 2.1 ± .9 d; P = .65) or postoperative outcomes between the 2 groups. There were no episodes of aspiration among the intervention group. Among RYGB patients, intervention patients had a shorter duration of nausea compared with standard patients. There was no significant difference in glycemic control among patients with and without diabetes.ConclusionsPreoperative carbohydrate drinks can be administered to bariatric surgery patients without significant risks. Carbohydrate loading preoperatively can decrease the duration of PONV in RYGB patients. Carbohydrate drinks can be safely included in bariatric ERAS protocols for patients with and without diabetes, although the benefits remain unknown. 相似文献
48.
49.
50.